대형주 바이오테크 주식 트레이딩 전략

### 주식 시장 탐색하기 생명공학 및 대형주를 위한 전략
* 📈 앞으로 지루한 날이 많겠지만, 특히 긴 연휴가 끝나면 **시장에서의 인내심은 보상을 얻을 수 있을 것**으로 예상됩니다.
* 💼 최근 미국 주식을 거래하고 있지만 추석 연휴 이후 **대형주 바이오테크 섹터에 특히 관심**을 두고 국내 시장에 집중하고 있습니다.
* 🔍 특히 최근 골든 라인 아래로 떨어지면서 시장 변동성 속에서 더 안전한 거래 기회를 제공하는 **알테오젠과 같은 대형주 바이오 의약품**을 공략하는 것이 중요합니다.
* 💡 "시장을 크게 끌어올리는 큰 강세 캔들이 이상적인 시나리오"이지만, 시장이 하락하면 **고점에서 매수하면 손실로 이어질 수 있으므로 주의**가 필요합니다.
* 📉 미국 및 국내 시장 모두에서 거래량이 감소했기 때문에 원치 않는 손실을 방지하기 위해 **고점에서 충동적인 구매를 피하는 것**이 필수적입니다.
* 🚀 **삼성바이오로직스, 현대로템**과 같은 종목은 특히 **주요 저항선을 안정적으로 돌파**할 경우 회복과 큰 폭의 상승 가능성을 보여줍니다.
* 🔑 파마리서치와 대봉엘에스 같은 종목의 경우 **임계 가격대 이상에서 마감**하면 추가 상승을 의미할 수 있어 확실한 수익 기회를 얻을 수 있습니다.
* ⏳ 궁극적으로 대형주에서 회복력과 전략적 진입 포인트에 집중하면 성공적인 트레이딩으로 이어질 수 있으며, **"주식 시장에서 인내심을 가진 사람이 승리하는 경향이 있다"**는 생각을 강화할 수 있습니다.

인내심을 갖고 거래하면 특히 탄력적인 대형주 생명공학 종목을 공략할 때 상당한 보상을 얻을 수 있습니다.

Although there will be many boring days ahead as we continue to wait, it seems that the market will definitely reward us for our patience. This holiday feels particularly long, but since I have started trading U.S. stocks as well, it seems to have shortened the duration of the break. I can't help but think that perhaps I'm trading U.S. stocks to fill the void left by such a long holiday or my trading addiction. Regardless of what happens next year, my main focus will still be on the domestic market, so I hope there's no misunderstanding that I am completely moving away from the U.S. market. Now, I will summarize the stocks I am currently interested in. If we look at it by sector, large-cap biotech is still maintaining a strong trend, so my goal after the Chuseok holiday is to make profits in the biotech sector, as long as this strong trend continues.

If we think positively about the current situation, a large bullish candle that pulls the market up significantly would be the ideal scenario. However, given the current market sentiment, even if the market rises, it may do so in a frustrating manner. There's also the downside that if one buys at the peak, they might end up being stuck, as the market is ready to decline at any moment. Therefore, I believe that now is the time to target large-cap biopharmaceuticals, specifically Alteogen, especially when it has dropped below the golden line. This approach is a safer trading strategy. The moment it falls below the golden line could be an opportunity, and since such a strong trend typically has good resilience, rather than blindly enduring a situation where the future is unclear, one can make easier judgments based on this resilience. Additionally, the methods for making money can vary from market to market, and it's clear that over the past few months...

Until recently, it wasn't quite like this, but now the trading volume in the market has definitely dried up. Whether the U.S. market is rising or falling, the trading volume has clearly diminished. Therefore, what should absolutely be avoided right now is recklessly chasing after peaks or buying impulsively at the highest points, no matter how appealing they may seem. If you make purchases based on imagination, you could face unwanted losses and suffering due to a lack of liquidity. However, there is one advantage when trading volume dries up: attention can become concentrated in one place. For example, last week, Daebong LS experienced a long upper wick, resulting in a disappointing outcome that aligns with the current market characteristics. Still, when attention is focused, it can break through to new highs, as everyone participates in the market with the same mindset. If attention is properly concentrated in one area, it can lead to significant movements.

A great opportunity for making profits can definitely arise if you are careful about entering at the right moment. By setting your focus on specific stocks, particularly those that are hitting new highs or have recently seen significant trading activity, you can create good opportunities for yourself. These stocks are not finished until they are truly finished. If you wait for the desired reactions to occur, you will surely catch the fish on your fishing line. As always, those who are patient in the stock market tend to come out on top. 

The first stock to mention is Alteogen, which can be referred to as a zombie stock these days, alongside Samsung Biologics. As I mentioned, the best scenario would be for Alteogen to produce a large bullish candle, pushing it one step higher. Ideally, it would rise above 150,000 won, which would be the best case scenario. There are various strategies to consider, whether to trade short-term or otherwise.

If we can definitely break through the all-time high, and if it finishes strongly with a large bullish candle accompanied by significant trading volume, then entering at the closing price that day or at a later time can lead to a favorable pullback the next day. If luck is on our side, we could also benefit from a double large bullish candle. Therefore, what is needed in the current market is a clear situation. With a clear situation, we can also employ various strategies. Samsung Biologics is currently maintaining a good trend, and as the price stabilizes at this level, there is a potential for a historical all-time high to be reached over time. Although the stock price is currently below 1 million won, it wouldn’t be strange for it to rise to 1.1 million or 1.2 million won in a month or two. Hence, I am consistently monitoring Samsung Biologics as a stock of interest, looking for ways to approach it by assessing its recovery below the golden line or considering entering at this price level.

If it collapses to the point where there is absolutely no answer, and if it gets pushed below the golden line and cannot recover, of course, the expected losses will increase significantly. However, the current position has not deviated from the previous high and is well-established, so I believe it is a reasonable position to consider. Next, I occasionally check the stocks where the long-term trend is changing, and recently, HK Inno has completely changed its trend, resulting in beautiful charts on both the weekly and monthly scales. You can understand this by looking at Krafton; there are often times when a stock that has been declining suddenly changes its trend and then rises in a stair-step fashion, making it hard to tell where it will end. If we are really lucky and strong, there is still quite a distance to break through the complete high.

It may be greedy, but if luck is on our side, we might be able to touch the nearby levels and then trade again. Due to this trend, there is a potential for momentum that allows us to reach nearby touch points, especially since it is a newly listed stock. If we consider it similar to Krafton, there’s a chance we could touch close to the all-time high if luck permits. The trend is changing, and trading volume is starting to pick up. Although there aren’t any transactions in the market right now, I've categorized it for now.

Next, I reclassified Hyundai, which has recently been showing reactions in the market. It fell below the golden line but recovered relatively quickly. Once we confirm this recovery, it indicates that the stock price is solidifying. If it does solidify, as I mentioned earlier, we could expect a recovery when it breaks the golden line, and if you want something more certain, it might be better to...

Even if I cannot enter this position, it is not a bad idea to wait until it closes with a large bullish candle that has proper trading volume. Moreover, since we are near the 50,000 won mark, if it gets pressed down during the day and trades around that level, I believe I can withstand a slight pullback near 50,000 won, as I see it as a place with a decent risk-reward ratio. If it continues to hit new highs without collapsing, there could be repeated stair-step increases. Therefore, I am continuously monitoring Hyundai Rotem. 

Next is Pharma Research. Recently, there was some reaction, but on September 11, there was a somewhat disappointing bearish candle. However, I believe it is crucial for it to close above 190,000 won. It recently broke through to a new high; September 6 was similar, as was September 11, when it was supported up to 200,000 won.

The closing price has not been able to break through 190,000 won. The sharpest timing is such that it doesn’t matter if you buy at a higher price; if it finishes distinctly above 190,000 won, then I believe there could be a medium-term stair-step rise in the stock price. This would create a sharp entry point. Even if the price fluctuates up and down during the day, I wouldn't necessarily enter, but if the closing price ends well, then we should consider a strategy for buying at the closing price or using a time unit. 

Next, regarding Daebong LS with an upper shadow, even if it has an upper shadow, as long as the trading volume is alive, it’s not over until it’s over. Similarly, if we judge based on the closing price, it can be easy to trade. If it closes above 2,850 won, then there might be further opportunities the next day.

A position can easily arise. It's important to make quick gains, so if we can wrap things up around this position, we may find opportunities for a rebound the next day or even a double long candle where we can take profits easily. It can also be viewed as a position where we can trade on a pullback from the bottom. However, since the market capitalization of this stock is not that large, unlike others with a market cap in the trillions, we should only take short-term gains in clear situations. Next is Yuhan Corporation, where the trend is still being maintained. Recently, it has been declining continuously, but the trends of large biotech stocks and Yuhan Corporation are still decent. If it falls below the golden line, then...

It seems that we can assess based on resilience. If there is a pullback, we should observe whether recovery occurs within three trading days. If recovery happens, we can take profits corresponding to that recovery. For example, if we break the golden line and finish there, we could enter at the closing price that day, and if the resilience looks good, we could take a short profit based on that recovery. Alternatively, after the recovery, we might aim for a bit more profit with expectations of additional upward movement. 

To summarize my two representative trading strategies: in large-cap stocks, when trading volume based on resilience is below the golden line, if a strong bullish candle that can pull all the money into the market appears, like on August 28th with YuHan Pharmaceutical, the next day, no matter what, it is likely to rebound effectively. If we are lucky, we might even capture a double bullish candle. This is a definite situation.

If you focus on just two main factors when trading, it seems possible to trade without significant risks. Although there will be many boring days ahead as you continue to wait, the market surely rewards you for the time you spend waiting.

현재 인기 관심주 모든 돈이 몰린다

안녕하세요. 창원개미TV입니다. 저는 오직 유튜브에서만 활동합니다. 사칭으로 인한 피해 조심하시기 바랍니다. 
사적인 제안이나 유료광고는 받지 않습니다.
실전투자에서 겪은 경험을 토대로 최대한 좋은영상을 제공해드리기 위해서 노력하고있습니다. 숨김과 거짓없이 초심그대로 최대한 성실하게 방송하겠습니다.

창원개미TV

긴 연휴 동안 주식 시장 탐색하기

긴 연휴로 지루했지만 미국 주식 거래가 공백을 메우는 데 도움이 되었습니다.

연휴가 끝난 후에도 대형주 바이오테크에 대한 관심이 높아지면서 국내 시장에 초점이 맞춰져 있습니다.

현재 시장 분위기는 거래량이 감소하는 등 조심스러운 상황이기 때문에 충동 매수를 피하고 알테오젠과 같은 탄력적인 종목을 공략하는 것이 중요합니다.

신중한 타이밍으로 최고가를 경신하는 특정 종목에 집중하면 수익 기회를 창출할 수 있습니다.

알테오젠과 삼성바이오로직스는 가격 상승 가능성이 큰 주요 관심 종목으로 꼽히고 있습니다.

HK이노, 크래프톤과 같은 종목의 장기 추세 변화를 모니터링하는 것도 좋은 투자 기회로 이어질 수 있습니다.

신규 상장 주식 및 현대자동차 트레이딩 인사이트

신규 상장 종목에는 모멘텀이 있으며, 가까운 터치 포인트와 사상 최고가에 도달할 가능성이 있습니다.

현대차의 주가는 골든라인 아래로 떨어진 후 빠른 회복세를 보이고 있으며, 주가가 견고해지면 회복과 강세 움직임으로 이어질 수 있습니다.

파마리서치 주가가 19만원 이상으로 마감해야 긍정적인 전망이 가능하며, 최근 지지선은 추가 상승 가능성을 시사하고 있습니다.

종가는 190,000원 돌파에 어려움을 겪고 있으며, 이 수준 이상으로 마감할 경우 중기 상승 가능성이 있습니다.

대봉엘에스는 상단 그림자가 있지만 2,850원 이상으로 마감하면 거래 기회가 있을 수 있습니다.

유한양행의 추세는 여전히 양호하지만 골든라인 아래로 떨어지면 모멘텀에 변화가 있을 수 있습니다.

회복력에 기반한 트레이딩 전략

트레이딩에서는 하락 후 3일 이내에 회복하는 데 중점을 두고 회복력을 평가하는 것이 중요합니다.

회복을 통해 수익을 얻을 수 있으며, 상승으로 인한 추가 수익 가능성도 있습니다.

두 가지 주요 전략은 강한 상승 캔들이 있는 대형주 트레이딩과 효과적인 반등을 기다리며 리스크를 최소화하는 것입니다.